As anxiety and stress become more prevalent in contemporary life, medical professionals such as pathologists, neurologists, and psychiatrists are increasingly prescribing benzodiazepines. These substances may offer short-term relief for patients; however, they pose significant long-term risks, as thousands of users become dependent on them. This issue has led experts to describe the situation as a silent epidemic, highlighting the potential dangers arising from these medications.

The article presents a personal account of a 32-year-old woman, Eleytheria M., who began experiencing panic attacks during the COVID-19 pandemic when a family member required hospitalization. She describes the overwhelming sensation of her heart racing and the fear of being unable to withdraw from the medication. Such narratives underscore the emotional toll that addiction and the dependency on benzodiazepines can have on individuals.

Furthermore, the piece emphasizes that the process of detoxification from benzodiazepines is complicated and painful, adding to the urgency for public awareness about the risks associated with their use. As health professionals advocate for better management of anxiety and stress without reliance on these drugs, the article calls for a critical examination of the current medical practices surrounding benzodiazepine prescriptions.